According to Tandem Diabetes Care
's latest financial reports the company has a price-to-book ratio of 7.53.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 6.15 | -6.38% |
2022-12-31 | 6.57 | -70.25% |
2021-12-31 | 22.1 | 35.91% |
2020-12-31 | 16.2 | -10.54% |
2019-12-31 | 18.2 | 9.08% |
2018-12-31 | 16.6 | -2131.93% |
2017-12-31 | -0.8193 | -92.63% |
2016-12-31 | -11.1 | -297.44% |
2015-12-31 | 5.63 | 2.27% |
2014-12-31 | 5.50 | 7.66% |
2013-12-31 | 5.11 | |
2012-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.25 | -30.29% | ๐บ๐ธ USA |
Medtronic MDT | 2.07 | -72.54% | ๐ฎ๐ช Ireland |
ICU Medical
ICUI | 1.14 | -84.90% | ๐บ๐ธ USA |
DexCom DXCM | 22.4 | 197.86% | ๐บ๐ธ USA |
Insulet PODD | 16.6 | 120.21% | ๐บ๐ธ USA |